Support our Foundation of Myology project
1385 news items
Long-term efficacy of nusinersen varies according to the frequency of injection
On 20/06/2025
Japanese researchers have compared two protocols, Japanese and European, for administering nusinersen in the treatment of SMA: for regulatory reasons, the Japanese protocol involves only…
Risdiplam tablets approved at European level
On 19/06/2025
Already available in the oral solution form, which can be stored in the refrigerator or, exceptionally, at room temperature for up to 5 days, risdiplam…
A case of acquired and reversible rod myopathy following leukaemia
On 19/06/2025
Researchers at the Créteil Neuromuscular Disease Reference Centre report the rather exceptional case of a patient who developed myopathic symptoms during an immunological complication (graft-versus-host…
Exploring the infinitely small – Interview with Stéphane Vassilopoulos
On 16/06/2025
An expert in cell biology and molecular biology, Stéphane Vassilopoulos is co-director of the ‘Muscle cell organization and therapy of dominant centronuclear myopathy‘ team at…
Va-C-Nemus reassures on the safety of vaccination against Covid-19 in NMD
On 16/06/2025
Launched in 2021, the Va-C-Nemus national prospective observational study involved 1,020 adults with a neuromuscular disease of genetic or autoimmune origin, 18% of whom were…
Seeing our muscles in action – Interview with Constantin Slioussarenko
On 12/06/2025
Constantin Slioussarenko, an engineer by training, is a researcher in the NMR and Spectroscopy Laboratory, co-directed by Harmen Reyngoud and Benjamin Marty, at the Neuromuscular…
Building the Muscle Atlas – Interview with Bruno Cadot
On 11/06/2025
Bruno Cadot is head of research in the ‘Signalling pathways and striated muscles’ team led by Antoine Muchir at the Center of Research in Myology…
The evolution of the new Morimoto-Ruy-Malicdan syndrome described in two brothers
On 10/06/2025
In a previous study published in 2024, Marie Morimoto et al. described nine cases of a new congenital myopathy linked to biallelic variants of the…
Towards a reassessment of certain contraindications to the use of drugs in autoimmune myasthenia gravis
On 03/06/2025
American researchers have investigated the possible complications associated with the use of several classes of antibiotics known to be harmful to myasthenia gravis patients: data…
The association of dermatomyositis and encephalopathy is exceptional but should be noted
On 02/06/2025
Mexican clinicians report the clinical and immunological data of three patients with concomitant encephalopathy and dermatomyositis (DM): the three patients were adults in their fifties…
Rising incidence of motor neurone disease in France before the Covid-19 crisis
On 30/05/2025
Using data from the French National Health Data System (SNDS), a French team has carried out a study of changes in the incidence of motor…
No additional long-term beneficial effects for the bisoprolol-perindopril combination
On 28/05/2025
British clinicians report the long-term results of a prophylactic treatment for cardiomyopathy in Duchenne muscular dystrophy (DMD): the combination of perindopril (a conversion enzyme inhibitor)…
Variable severity of SMA in patients with four copies of the SMN2 gene
On 27/05/2025
A study published using data from the SMA France register, set up in 2020, shows a wide variety of phenotypes in patients with SMN1-related proximal…
Towards conditional authorisation of givinostat in Europe for walking DMD patients aged 6 and over on corticosteroids
On 26/05/2025
Givinostat, a histone deacetylase (HDAC) inhibitor that acts on muscle fibrosis and inflammation in Duchenne muscular dystrophy, should be authorised in Europe very soon, under…
A new non-invasive biomarker for investigating demyelinating neuropathies
On 23/05/2025
An international consortium led by researchers in Nantes has developed and studied in real life a new non-invasive method for demyelinating neuropathies such as CMT1A,…
A model to predict the distance covered during the 6MWT in Pompe disease
On 22/05/2025
Researchers from the Laboratory of Physiology and Neuromuscular Evaluation at the Institute of Myology have developed and validated predictive models for the performance of the…
The Institute’s teams at the 5th International Meeting on Laminopathies from 21 to 23 May in Paris
On 21/05/2025
The 5th International Meeting on Laminopathies, being held in Paris from 21 to 23 May, brings together international experts in nuclear envelope proteins and associated…
A natural history study of upper limb function in SMA type II
On 20/05/2025
The Spanish network responsible for monitoring patients with SMN1-related proximal spinal muscular atrophy (SMA) retrospectively studied the evolution of upper limb function in SMA type…
Researchers from the Institute at the 15th MGFA International Conference
On 15/05/2025
Institute researchers at the 15th International MGFA ConferenceInstitute experts presented their work at the 15th International MGFA Conference on myasthenia gravis and associated disorders, held…
Results of a European survey on the management of bone problems in neuromuscular diseases
On 14/05/2025
The partial or total immobility caused by many neuromuscular diseases, whether or not associated with the deleterious effect of corticosteroid therapy, is often the cause…
